Effectiveness, Safety and Tolerability Study of RP-G28 for Symptoms Associated With Lactose Intolerance

NCT01113619 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Lactose Intolerance

Interventions

DRUG: RP-G28 or placebo
DRUG: RP-G28 or placebo

Sponsor

Ritter Pharmaceuticals, Inc.